These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27522248)

  • 1. Tissue inhibitor of metalloproteinase-3 (TIMP3) expression decreases during melanoma progression and inhibits melanoma cell migration.
    Das AM; Bolkestein M; van der Klok T; Oude Ophuis CM; Vermeulen CE; Rens JA; Dinjens WN; Atmodimedjo PN; Verhoef C; Koljenović S; Smits R; Ten Hagen TL; Eggermont AM
    Eur J Cancer; 2016 Oct; 66():34-46. PubMed ID: 27522248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma.
    Das AM; Koljenović S; Oude Ophuis CM; van der Klok T; Galjart B; Nigg AL; van Cappellen WA; Noordhoek Hegt V; Dinjens WN; Atmodimedjo PN; Vermeulen CE; Verhoef C; Eggermont AM; ten Hagen TL
    Eur J Cancer; 2016 Jan; 53():135-43. PubMed ID: 26707830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor.
    Martin del Campo SE; Latchana N; Levine KM; Grignol VP; Fairchild ET; Jaime-Ramirez AC; Dao TV; Karpa VI; Carson M; Ganju A; Chan AN; Carson WE
    PLoS One; 2015; 10(1):e0115919. PubMed ID: 25587717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
    Guo H; Cheng Y; Martinka M; McElwee K
    Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demethylation of TIMP2 and TIMP3 Inhibits Cell Proliferation, Migration, and Invasion in Pituitary Adenomas.
    Yang Y; Huang F; Wu X; Huang C; Li Y
    Discov Med; 2024 May; 36(184):971-980. PubMed ID: 38798256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
    Huang HL; Liu YM; Sung TY; Huang TC; Cheng YW; Liou JP; Pan SL
    Theranostics; 2019; 9(22):6676-6689. PubMed ID: 31588243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.
    Wang J; Hua W; Huang SK; Fan K; Takeshima L; Mao Y; Hoon DS
    Oncotarget; 2015 Oct; 6(30):30165-77. PubMed ID: 26334503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration.
    Das AM; Seynhaeve AL; Rens JA; Vermeulen CE; Koning GA; Eggermont AM; Ten Hagen TL
    Angiogenesis; 2014 Jan; 17(1):163-77. PubMed ID: 24221409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer.
    Adissu HA; McKerlie C; Di Grappa M; Waterhouse P; Xu Q; Fang H; Khokha R; Wood GA
    Prostate; 2015 Dec; 75(16):1831-43. PubMed ID: 26332574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion.
    Khosravi S; Tam KJ; Ardekani GS; Martinka M; McElwee KJ; Ong CJ
    J Invest Dermatol; 2015 May; 135(5):1358-1367. PubMed ID: 25562667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of expression of TIMP3 in clear cell renal cell carcinoma.
    Masson D; Rioux-Leclercq N; Fergelot P; Jouan F; Mottier S; Théoleyre S; Bach-Ngohou K; Patard JJ; Denis MG
    Eur J Cancer; 2010 May; 46(8):1430-7. PubMed ID: 20194016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel DNA methylation markers with potential prognostic relevance in advanced malignant melanoma identified using COBRA assays.
    Kaehler KC; Politz O; Henderson D; Ulbrich HF; Hauschild A; Mund C; Egberts F
    Melanoma Res; 2015 Jun; 25(3):225-31. PubMed ID: 25919928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
    Feng H; Cheung AN; Xue WC; Wang Y; Wang X; Fu S; Wang Q; Ngan HY; Tsao SW
    Gynecol Oncol; 2004 Aug; 94(2):375-82. PubMed ID: 15297175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
    Welinder C; Pawłowski K; Szasz AM; Yakovleva M; Sugihara Y; Malm J; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Laurell T; Wieslander E; Marko-Varga G
    PLoS One; 2017; 12(4):e0176167. PubMed ID: 28445515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Tip60 in human melanoma cell migration, metastasis, and patient survival.
    Chen G; Cheng Y; Tang Y; Martinka M; Li G
    J Invest Dermatol; 2012 Nov; 132(11):2632-41. PubMed ID: 22673729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
    de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of XRCC1 confers a metastatic phenotype to melanoma cells and is associated with poor survival in patients with melanoma.
    Bhandaru M; Martinka M; Li G; Rotte A
    Pigment Cell Melanoma Res; 2014 May; 27(3):366-75. PubMed ID: 24410901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
    Anania MC; Sensi M; Radaelli E; Miranda C; Vizioli MG; Pagliardini S; Favini E; Cleris L; Supino R; Formelli F; Borrello MG; Pierotti MA; Greco A
    Oncogene; 2011 Jul; 30(27):3011-23. PubMed ID: 21339735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the tissue inhibitor of metalloproteinase-3 (TIMP3) gene in pancreatic adenocarcinomas.
    Fendrich V; Slater EP; Heinmöller E; Ramaswamy A; Celik I; Nowak O; Chaloupka B; Gerdes B; Bartsch DK
    Pancreas; 2005 Mar; 30(2):e40-5. PubMed ID: 15714128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances.
    Han XG; Li Y; Mo HM; Li K; Lin D; Zhao CQ; Zhao J; Tang TT
    Tumour Biol; 2016 Jul; 37(7):8857-67. PubMed ID: 26749283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.